| BIOVAXYS TECHNOLOGY CORP. |
| Kanada |
| Gesundheit |
| CA09076M2004 / A41C58 |
| 5LB0 (Frankfurt) |
| FRA:5LB0, ETR:5LB0, 5LB0:GR |
| - |
| https://www.biovaxys.com/ |
|
BioVaxys Technology Corp., a clinical-stage biotec..
>Volltext.. |
| 5.03 Mio. EUR |
| 5.11 Mio. EUR |
| - |
| -3.07 Mio. EUR |
| -3.79 Mio. EUR |
| -0.14 EUR |
| 0.08 Mio. EUR |
| - |
| -1.86 Mio. EUR |
| - |
| - |
| -17.07% |
| - |
| - |
| - |
| - |
| BIOVAXYS |
| 22.11.25 |
|